Transparency Market Research includes new market research report "Glaucoma Pharmaceuticals Market" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 04/07/2014 -- Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/glaucoma-pharmaceuticals-market.html
Glaucoma cannot be cured with various medications which could prevent the complete vision loss. These medications include eye drops, surgery and oral medications. Currently, the most widely used treatment for glaucoma includes eye drops and oral medications. Eye drops include Travatan Z®, Xalatan®, Lumigan®,Alphagan®P, iopidine®, Trusopt®, Azopt™, Diamox®, Combigan™, Cosopt® and Neptazane®. Lack of improvement in glaucoma patients with eye drops may compel the physicians to opt for second line of treatment which includes, prescribed oral medication which is in the form of carbonic anhydrase inhibitor.
Population above the age of 40 years is more prone for this disease due to malfunctioning of various eye structures. Rise in geriatric population around globe would augment the growth of this market. In addition, strong reimbursement policies in various nations for the treatment of this disease would also enhance the growth of this market. Recently, the Glaucoma Foundation (GF) of the U.S. granted around USD 40,000 to the researchers to improve the quality life of glaucoma patients. Despite all these advantages, various risks associated with glaucoma treatment would hinder the growth of this market. These risks include fatigue, headache, drowsiness, allergy, reduced pulse rate, shortness of breath, depression, eye redness, itching, burning and blurred vision. In addition, laser surgeries would outwit this market which would also hamper its growth. The laser surgeries would overtake over chemo and eye drop therapy since it would serve wide range of patients with less side effects.
Some of the market players in glaucoma pharmaceutical market include Acadia Pharmaceuticals Inc., Allergan Inc., Inotek Pharmaceuticals Corporation, Merck & Co. Inc., Santen Pharmaceutical Co.Ltd. and Novartis International AG amongst other significant players.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1592
90 State Street,
Albany NY - 12207
Browse Market Research Blog: